GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in therapeutic studies, largely due to its remarkable impact on treating conditions such as type 2 diabetes and excess body fat. Recent studies have revealed that in addition to glucose management, GLP-1 drugs offer potential for circulatory health and p… Read More